A Study to Assess the Effectiveness and Safety of 2 Dosage Regimens of Oral Fidrisertib (IPN60130) for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP).
Clinical trial NCT05039515 · TERMINATED
Trial details
- NCT number
- NCT05039515
- Sponsor
- Clementia Pharmaceuticals Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-01
- Primary completion
- 2026-03-27
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.